InChI=1S/C56H99NO13/c1-8-10-12-14-16-18-20-22-23-24-25-26-27-29-31-33-35-37-39-41-52(63)57-49(50(66-45(4)59)40-38-36-34-32-30-28-21-19-17-15-13-11-9-2)42-65-56-55(69-48(7)62)54(68-47(6)61)53(67-46(5)60)51(70-56)43-64-44(3)58/h38,40,49-51,53-56H,8-37,39,41-43H2,1-7H3,(H,57,63)/b40-38+/t49-,50+,51+,53-,54-,55+,56+/m0/s1 |
BDPASYIZEHXBLJ-SLYLSTMUSA-N |
N([C@@H](CO[C@H]1[C@@H]([C@@H](OC(=O)C)[C@H]([C@@H](COC(=O)C)O1)OC(=O)C)OC(=O)C)[C@H](OC(=O)C)/C=C/CCCCCCCCCCCCC)C(CCCCCCCCCCCCCCCCCCCCC)=O |
|
human xenobiotic metabolite
Any human metabolite produced by metabolism of a xenobiotic compound in humans.
|
|
View more via ChEBI Ontology
Outgoing
|
N-(docosanoyl)-1-(2',3',4',6'-tetraacetylβ-D-galactosyl)-3-acetylsphingosine
(CHEBI:136366)
has functional parent
docosanoic acid
(CHEBI:28941)
N-(docosanoyl)-1-(2',3',4',6'-tetraacetylβ-D-galactosyl)-3-acetylsphingosine
(CHEBI:136366)
has role
human xenobiotic metabolite
(CHEBI:76967)
N-(docosanoyl)-1-(2',3',4',6'-tetraacetylβ-D-galactosyl)-3-acetylsphingosine
(CHEBI:136366)
is a
cerebroside
(CHEBI:23079)
N-(docosanoyl)-1-(2',3',4',6'-tetraacetylβ-D-galactosyl)-3-acetylsphingosine
(CHEBI:136366)
is a
galactolipid
(CHEBI:5254)
N-(docosanoyl)-1-(2',3',4',6'-tetraacetylβ-D-galactosyl)-3-acetylsphingosine
(CHEBI:136366)
is a
glycosylceramide
(CHEBI:62941)
|
|
(2S,3R,4E)-2-(docosanoylamino)-1-[(2,3,4,6-tetra-O-acetyl-β-D-galactopyranosyl)oxy]octadec-4-en-3-yl acetate
|
2,3,4,6-β-tetraacetyl-D-galactosyl-N-(docosanoyl)-3-acetylsphing-4-enine
|
ChEBI
|
2,3,4,6-β-tetraacetyl-D-galactosyl-N-(docosanoyl)-3-acetylsphingosine
|
ChEBI
|
3-O-acetyl-sphingosine-2,3,4,6-tetra-O-acetyl-GalCer(d18:1/22:0)
|
LIPID MAPS
|
FMC-5(d18:1/22:0)
|
LIPID MAPS
|
N-(docosanoyl)-1-(2',3',4',6'-tetraacetylβ-D-galactosyl)-3-acetylsphing-4-enine
|
ChEBI
|
N-(docosanoyl)-1-beta-(2',3',4',6'-tetra-O-acetyl-galactosyl)-3-O-acetyl-sphing-4-enine
|
LIPID MAPS
|
11241148
|
Reaxys Registry Number
|
Reaxys
|
|